Related Experiment Video
Updated: Jun 30, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Systemic Gaps and Roadmap for Integrated Care for Post-tuberculosis Lung Disease in Ethiopia: A Narrative Review
Abraham T Ajema1, Surafel N Firdawok2, Tizita Shimelis2
1Department of Medical/Clinical Services, AIDS Healthcare Foundation, Hawassa, ETH.
Abstract:
Post-tuberculosis lung disease (PTLD) is a major cause of chronic respiratory impairment globally, yet it remains a critically neglected complication in high-burden, low-resource settings. This narrative review synthesizes evidence on PTLD, with a specific focus on Ethiopia, to analyze the health system gaps and propose actionable solutions. We conducted a narrative review of published and grey literature on the clinical burden, socioeconomic impact, and health system challenges of PTLD, with a particular emphasis on Ethiopia. Evidence was selected for relevance to PTLD phenotypes, diagnosis, management, and health system integration. PTLD, encompassing conditions like bronchiectasis, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, affects a substantial proportion of tuberculosis (TB) survivors, leading to chronic respiratory symptoms, lung function disability, and socioeconomic impact. In Ethiopia, despite its inclusion as a priority lung disease in the national strategic plan, critical gaps persist. These include a profound lack of clinical and patient awareness, severely limited diagnostic capacity (spirometry, imaging), absent treatment and rehabilitation pathways, a scarcity of local epidemiological and implementation research, and unaddressed policy system barriers that impact infectious and chronic disease care. Ethiopia's policy recognition of PTLD is a pivotal first step. An urgent, coordinated effort is required to translate this into functional, equitable care. Success depends on concurrent action by researchers to generate local evidence, public health institutes to integrate surveillance and develop guidelines, clinicians to pioneer service delivery models, and policymakers to mandate and fund integration. Bridging the PTLD care gap is essential to safeguard the long-term health of TB survivors and strengthen the health system's capacity to manage chronic disease.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis